-
Human medicines European public assessment report (EPAR): Dazublys, trastuzumab, Status: Opinion
28 Apr 2025 10:38 GMT
… authorisation for the medicinal product Dazublys, intended for the treatment of breast … medicinal product. It is highly similar to the reference product Herceptin … and efficacy to Herceptin (trastuzumab). More information on biosimilar medicines can be …
-
ALX Oncology’s CD47-blocker and Keytruda combo fails in two Phase II trials
28 Apr 2025 13:12 GMT
… trials as a first-line treatment … trials investigating evorpacept with other anti-cancer antibodies, including Cyramza (ramucirumab), Herceptin … a future medical meeting.
Evorpacept … trial failures and clinical holds by the US Food and Drug Administration (FDA …
-
The Targeted Pulse: AI Cancer Diagnosis, Breast Cancer Treatment Updates, and More
27 Apr 2025 16:17 GMT
… with the standard treatment of taxane, trastuzumab (Herceptin), and pertuzumab. … the FDA, the design of this registrational trial has … study.
Published in Nature Medicine, the study also showed … represents the first antibody-drug conjugate combined with an …
-
Aurobindo Pharma arm CuraTeQ Biologics gets positive opinion for breast cancer drug Dazublys from EMA
26 Apr 2025 08:13 GMT
… that the Committee for Medicinal Products for Human Use … trastuzumab biosimilar, for the treatment of HER2-positive metastatic and … the reference biologic product Herceptin in terms of pharmacokinetics … of products from bulk drug substance to fill-finish …
-
ALX Oncology Reports ASPEN-03 and ASPEN-04 Phase 2 Trials Evaluating Evorpacept with a Checkpoint Inhibitor for the Treatment of Head and Neck Cancers Did Not Meet Primary Endpoints
25 Apr 2025 13:00 GMT
… several studies when combined with HERCEPTIN®, zanidatamab and RITUXAN®,” … -04 trials will be submitted to a future medical meeting. … the availability of new treatment modalities, underscoring a need … U.S. Food and Drug Administration (FDA) has granted Fast …
-
SUNLIGHT Trial Defines CRC in the Refractory Setting
24 Apr 2025 16:50 GMT
… in the Department of Medical Oncology and Therapeutics Research … additional treatment options based on findings from the SUNLIGHT trial … [Tukysa] plus trastuzumab [Herceptin].5 We also have KRAS … the lookout for clinical trials to improve outcomes.
REFERENCES …
-
The Importance of Biobanking in Molecular Diagnostics and Drug Development
24 Apr 2025 21:31 GMT
… may predispose certain diseases. Traditional treatments like chemotherapy and radiation have … samples for identifying potential drug targets, such as Herceptin, and provide sample … samples for assessing drug safety and efficacy before clinical trials, such as …
-
Zanidatamab Is a Breakthrough in HER2- Positive Biliary Tract Cancer Treatment
24 Apr 2025 14:45 GMT
… Jazz Pharmaceuticals) marks a pivotal moment in the treatment of … therapies, such as trastuzumab (Herceptin; Roche) or pertuzumab (Perjeta … in addressing an unmet medical need.
Zanidatamab is … ;/www.accessdata.fda.gov/drugsatfda_docs/label…
-
Evorpacept With Keytruda Did Not Elicit Responses in Head and Neck Cancer
25 Apr 2025 15:23 GMT
… the treatment of HNSCC. However, there are multiple clinical trials … studies when combined with Herceptin (trastuzumab), zanidatamab and Rituxan … cancer. The ASPEN-04 trial, according to the listing … an unmet medical need, and orphan drug designation is …
-
The Miraculous Healing Power of Green Tea: Unlocking the Potent Antioxidants That Big Pharma Doesnât Want You to Know About
28 Apr 2025 14:16 GMT
… the effects of chemotherapy drugs like Herceptin.
- Prostate Cancer: … triglycerides more effectively than statins in some studies, … effective healing than synthetic pharmaceuticals.
Yet, you must …
"Cancer Prevention and Treatment by Green Tea" …